nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Angiogenesis as a new target for cancer treatment
|
Ono, M. |
|
1996 |
38 |
1 |
p. S78-S82 |
artikel |
2 |
A novel antitumor compound, NC-190, induces topoisomerase II-dependent DNA cleavage and DNA fragmentation
|
Yamagishi, T. |
|
1996 |
38 |
1 |
p. 29-34 |
artikel |
3 |
Antitumor activity of interleukin 12 in preclinical models
|
Brunda, M. J. |
|
1996 |
38 |
1 |
p. S16-S21 |
artikel |
4 |
Antitumor and antimetastatic effects of interleukin 12
|
Fujiwara, H. |
|
1996 |
38 |
1 |
p. S22-S26 |
artikel |
5 |
Application of interleukin 12 to antitumor cytokine and gene therapy
|
Nishimura, T. |
|
1996 |
38 |
1 |
p. S27-S34 |
artikel |
6 |
A weekly alternating chemotherapy regimen with low toxicity for the treatment of aggressive lymphoma
|
Bower, M. |
|
1996 |
38 |
1 |
p. 106-109 |
artikel |
7 |
Bioavailability of subcutaneous 5-fluorouracil: a case report
|
Eatock, M. M. |
|
1996 |
38 |
1 |
p. 110-112 |
artikel |
8 |
Biologic effects of thrombopoietin, the Mpl ligand, and its therapeutic potential
|
Papayannopoulou, Thalia |
|
1996 |
38 |
1 |
p. S69-S73 |
artikel |
9 |
Biology and clinical potential of stem-cell factor
|
Glaspy, J. |
|
1996 |
38 |
1 |
p. S53-S57 |
artikel |
10 |
Cloning of thrombopoietin and its therapeutic potential
|
Miyazaki, Hiroshi |
|
1996 |
38 |
1 |
p. S74-S77 |
artikel |
11 |
Costimulation of T-cell-mediated tumor immunity
|
Hellström, Karl Erik |
|
1996 |
38 |
1 |
p. S40-S41 |
artikel |
12 |
Differential effects of c-fms and c-kit ligands on the lineage development of the lymphohematopoietic cell line EML C1
|
Tsai, Schickwann |
|
1996 |
38 |
1 |
p. S58-S63 |
artikel |
13 |
Doxorubicin-induced cardiotoxicity monitored by ECG in freely moving miceA new model to test potential protectors
|
van Acker, S. A. B. E. |
|
1996 |
38 |
1 |
p. 95-101 |
artikel |
14 |
Effect of interleukin 11 on normal and pathological thrombopoiesis
|
Teramura, M. |
|
1996 |
38 |
1 |
p. S99-S102 |
artikel |
15 |
Effect of oral chemotherapy on the mitochondrial size of mouse intestinal cells
|
Bessler, Hanna |
|
1996 |
38 |
1 |
p. 35-38 |
artikel |
16 |
Effects of combined and sequential treatment with tamoxifen and the aromatase inhibitor vorozole on 7,12-dimethylbenz(a) anthracene-induced mammary carcinoma in the rat
|
Ginckel, Robert Van |
|
1996 |
38 |
1 |
p. 21-28 |
artikel |
17 |
European School of Oncology European consensus on the use of granulocyte colony-stimulating factor: the example of breast cancer
|
Antoine, Eric C. |
|
1996 |
38 |
1 |
p. S103-S109 |
artikel |
18 |
Factors for rapid and sustained hematopoietic reconstitution by circulating progenitor-cell transplantation in non-Hodgkin’s lymphoma
|
Barbui, Tiziano |
|
1996 |
38 |
1 |
p. S110-S114 |
artikel |
19 |
Flavone acetic acid increases the cytotoxicity of mitomycin C when combined with hyperthermia
|
Takeuchi, H. |
|
1996 |
38 |
1 |
p. 1-8 |
artikel |
20 |
Glutathione S-transferase and glutathione peroxidase are essential in the early stage of Adriamycin resistance before P-glycoprotein overexpression in HOB1 lymphoma cells
|
Lee, W.-P. |
|
1996 |
38 |
1 |
p. 45-51 |
artikel |
21 |
Granulocyte colony-stimulating factor-induced mobilization of peripheral blood stem cells for autologous and allogeneic transplantation
|
Harada, M. |
|
1996 |
38 |
1 |
p. S115-S119 |
artikel |
22 |
Hepatocyte growth factor in lung morphogenesis and tumor invasion: role as a mediator in epithelium-mesenchyme and tumor-stroma interactions
|
Matsumoto, Kunio |
|
1996 |
38 |
1 |
p. S42-S47 |
artikel |
23 |
Hyaluronidase pretreatment produces selective melphalan enrichment in malignant melanoma implanted in nude mice
|
Muckenschnabel, Ingo |
|
1996 |
38 |
1 |
p. 88-94 |
artikel |
24 |
Imidazoacridinones arrest cell-cycle progression in the G2 phase of L1210 cells
|
Augustin, E. |
|
1996 |
38 |
1 |
p. 39-44 |
artikel |
25 |
Immunoconjugates and immunotoxins for therapy of solid tumors
|
Hellström, I. |
|
1996 |
38 |
1 |
p. S35-S36 |
artikel |
26 |
Impact of different fluorouracil biochemical modulators on cellular dihydropyrimidine dehydrogenase
|
Haaz, M. C. |
|
1996 |
38 |
1 |
p. 52-58 |
artikel |
27 |
Inhibition of etoposide elimination in the isolated perfused rat liver by Cremophor EL and Tween 80
|
Ellis, Andrew G. |
|
1996 |
38 |
1 |
p. 81-87 |
artikel |
28 |
Intravesical idarubicin: a dose-finding study
|
Boccardo, F. |
|
1996 |
38 |
1 |
p. 102-105 |
artikel |
29 |
In vitro model of toxin therapy targeted against murine myeloid leukemia cells
|
Tojo, A. |
|
1996 |
38 |
1 |
p. S37-S39 |
artikel |
30 |
Is interleukin 3 active in anticancer drug-induced thrombocytopenia?
|
Newland, Adrian C. |
|
1996 |
38 |
1 |
p. S83-S88 |
artikel |
31 |
6-Mercaptopurine dose escalation and its effect on drug tolerance in childhood lymphoblastic leukaemia
|
Welch, J. C. |
|
1996 |
38 |
1 |
p. 113-116 |
artikel |
32 |
New promising anticancer agents in development: what comes next?
|
Verweij, Jaap |
|
1996 |
38 |
1 |
p. S3-S10 |
artikel |
33 |
Optimal schedule for administering granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in non-small-cell lung cancer
|
Soda, Hiroshi |
|
1996 |
38 |
1 |
p. 9-12 |
artikel |
34 |
Phase II study of recombinant human interleukin 3 administration following carboplatin and etoposide chemotherapy in small-cell lung cancer patients
|
Kudoh, S. |
|
1996 |
38 |
1 |
p. S89-S95 |
artikel |
35 |
Plasma pharmacokinetics and urinary excretion of the polyamine analogue 1, 19-bis(ethylamino)-5, 10, 15-triazanonadecane in CD2F1 mice
|
Eiseman, J. L. |
|
1996 |
38 |
1 |
p. 13-20 |
artikel |
36 |
Postlabeling detection of DNA adducts of antitumor alkylating agents
|
Zhou, Guo-Hao |
|
1996 |
38 |
1 |
p. 71-80 |
artikel |
37 |
Progress in preclinical and clinical studies for the development of new anticancer drugs in Japan, with emphasis on taxanes
|
Saijo, N. |
|
1996 |
38 |
1 |
p. S11-S15 |
artikel |
38 |
Role of glycoprotein 130 and c-Kit signaling in proliferation and differentiation of human hematopoietic progenitor cells
|
Nakahata, T. |
|
1996 |
38 |
1 |
p. S64-S68 |
artikel |
39 |
ThioTEPA pharmacokinetics during intravesical chemotherapy: the influence of dose and volume of instillate on systemic uptake and dose rate to the tumour
|
Masters, J. R. W. |
|
1996 |
38 |
1 |
p. 59-64 |
artikel |
40 |
Thrombopoietic activity of recombinant human interleukin 11 in cancer patients receiving chemotherapy
|
Gordon, Michael S. |
|
1996 |
38 |
1 |
p. S96-S98 |
artikel |
41 |
Toxohormones responsible for cancer cachexia syndrome in nude mice bearing human cancer cell lines
|
Kajimura, Naoko |
|
1996 |
38 |
1 |
p. S48-S52 |
artikel |
42 |
Trifluoperazine as a modulator of multidrug resistance in refractory breast cancer
|
Murren, J. R. |
|
1996 |
38 |
1 |
p. 65-70 |
artikel |